Cargando…

Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects

Bastadins-6, -9 and -16 isolated from the marine sponge Ianthella basta displayed in vitro cytostatic and/or cytotoxic effects in six human and mouse cancer cell lines. The in vitro growth inhibitory effects of these bastadins were similar in cancer cell lines sensitive to pro-apoptotic stimuli vers...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathieu, Véronique, Wauthoz, Nathalie, Lefranc, Florence, Niemann, Hendrik, Amighi, Karim, Kiss, Robert, Proksch, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269779/
https://www.ncbi.nlm.nih.gov/pubmed/23519198
http://dx.doi.org/10.3390/molecules18033543
_version_ 1783376546478686208
author Mathieu, Véronique
Wauthoz, Nathalie
Lefranc, Florence
Niemann, Hendrik
Amighi, Karim
Kiss, Robert
Proksch, Peter
author_facet Mathieu, Véronique
Wauthoz, Nathalie
Lefranc, Florence
Niemann, Hendrik
Amighi, Karim
Kiss, Robert
Proksch, Peter
author_sort Mathieu, Véronique
collection PubMed
description Bastadins-6, -9 and -16 isolated from the marine sponge Ianthella basta displayed in vitro cytostatic and/or cytotoxic effects in six human and mouse cancer cell lines. The in vitro growth inhibitory effects of these bastadins were similar in cancer cell lines sensitive to pro-apoptotic stimuli versus cancer cell lines displaying various levels of resistance to pro-apoptotic stimuli. While about ten times less toxic than the natural cyclic bastadins, the synthetically derived 5,5'-dibromohemibastadin-1 (DBHB) displayed not only in vitro growth inhibitory activity in cancer cells but also anti-angiogenic properties. At a concentration of one tenth of its in vitro growth inhibitory concentration, DBHB displayed actual antimigratory effects in mouse B16F10 melanoma cells without any sign of cytotoxicity and/or growth inhibition. The serum concentration used in the cell culture media markedly influenced the DBHB-induced antimigratory effects in the B16F10 melanoma cell population. We are currently developing a specific inhalation formulation for DBHB enabling this compound to avoid plasmatic albumin binding through its direct delivery to the lungs to combat primary as well as secondary (metastases) tumors.
format Online
Article
Text
id pubmed-6269779
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62697792018-12-20 Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects Mathieu, Véronique Wauthoz, Nathalie Lefranc, Florence Niemann, Hendrik Amighi, Karim Kiss, Robert Proksch, Peter Molecules Article Bastadins-6, -9 and -16 isolated from the marine sponge Ianthella basta displayed in vitro cytostatic and/or cytotoxic effects in six human and mouse cancer cell lines. The in vitro growth inhibitory effects of these bastadins were similar in cancer cell lines sensitive to pro-apoptotic stimuli versus cancer cell lines displaying various levels of resistance to pro-apoptotic stimuli. While about ten times less toxic than the natural cyclic bastadins, the synthetically derived 5,5'-dibromohemibastadin-1 (DBHB) displayed not only in vitro growth inhibitory activity in cancer cells but also anti-angiogenic properties. At a concentration of one tenth of its in vitro growth inhibitory concentration, DBHB displayed actual antimigratory effects in mouse B16F10 melanoma cells without any sign of cytotoxicity and/or growth inhibition. The serum concentration used in the cell culture media markedly influenced the DBHB-induced antimigratory effects in the B16F10 melanoma cell population. We are currently developing a specific inhalation formulation for DBHB enabling this compound to avoid plasmatic albumin binding through its direct delivery to the lungs to combat primary as well as secondary (metastases) tumors. MDPI 2013-03-19 /pmc/articles/PMC6269779/ /pubmed/23519198 http://dx.doi.org/10.3390/molecules18033543 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Mathieu, Véronique
Wauthoz, Nathalie
Lefranc, Florence
Niemann, Hendrik
Amighi, Karim
Kiss, Robert
Proksch, Peter
Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects
title Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects
title_full Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects
title_fullStr Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects
title_full_unstemmed Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects
title_short Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects
title_sort cyclic versus hemi-bastadins. pleiotropic anti-cancer effects: from apoptosis to anti-angiogenic and anti-migratory effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269779/
https://www.ncbi.nlm.nih.gov/pubmed/23519198
http://dx.doi.org/10.3390/molecules18033543
work_keys_str_mv AT mathieuveronique cyclicversushemibastadinspleiotropicanticancereffectsfromapoptosistoantiangiogenicandantimigratoryeffects
AT wauthoznathalie cyclicversushemibastadinspleiotropicanticancereffectsfromapoptosistoantiangiogenicandantimigratoryeffects
AT lefrancflorence cyclicversushemibastadinspleiotropicanticancereffectsfromapoptosistoantiangiogenicandantimigratoryeffects
AT niemannhendrik cyclicversushemibastadinspleiotropicanticancereffectsfromapoptosistoantiangiogenicandantimigratoryeffects
AT amighikarim cyclicversushemibastadinspleiotropicanticancereffectsfromapoptosistoantiangiogenicandantimigratoryeffects
AT kissrobert cyclicversushemibastadinspleiotropicanticancereffectsfromapoptosistoantiangiogenicandantimigratoryeffects
AT prokschpeter cyclicversushemibastadinspleiotropicanticancereffectsfromapoptosistoantiangiogenicandantimigratoryeffects